CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 141 enrolled
Drug / intervention
Venofer (iron sucrose injection) +2 moredrug
Likely dose
Venofer (iron sucrose) 0.5–2.0 mg/kg intravenously up to 100 mg maximumAI-extracted
Key inclusion· 7
  • Age 2 to 21 years
  • On stable hemodialysis or peritoneal dialysis for ≥3 months
  • Non-dialysis dependent patients with GFR <60 mL/min/1.73m²
  • Hemoglobin 11 to 13.5 g/dL
Key exclusion· 9
  • Known hypersensitivity to iron sucrose
  • Severe disease of liver, cardiovascular, or hematopoietic system
  • Serious infection requiring hospitalization
  • Significant blood loss within last 3 months

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00239642
NCT00239642Phase 4Completed

Comparison of the Safety and Efficacy of Three Iron Sucrose Maintenance Regimens in Pediatric Chronic Kidney Disease (CKD) Patients

American Regent, Inc.·interventional·Posted Oct 17, 2005·Updated Nov 17, 2021

In Brief

A Phase 4 clinical trial evaluating Venofer (iron sucrose injection) for Anemia and Chronic Kidney Disease. Completed, enrolled 141 participants across 1 site.

Detailed Summary

Comparison of three potential iron sucrose maintenance regimens in pediatric chronic kidney disease (CKD) patients

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 17, 2005
Enrollment StartJul 1, 2005
Primary CompletionJan 1, 2009
Study CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 20.7 years ago

Interventions

Venofer (iron sucrose injection)drug

0.5 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously

Venofer (iron sucrose injection)drug

1.0 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously

Venofer (iron sucrose injection)drug

2.0 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously